Cargando…
Sorption of Interleukins 12 and 23 Using the Developed Magnetocontrollable Ustekinumab-Based Sorbent
The aim of the study was to assess the sorption capacity of Ustekinumab, a drug based on interleukins 12 (IL-12) and 23 (IL-23), when using it with a magnetocontrollable sorbent. MATERIALS AND METHODS. To reduce the concentration of proinflammatory cytokines (IL-12, IL-23), the blood of patients wit...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Privolzhsky Research Medical University
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596277/ https://www.ncbi.nlm.nih.gov/pubmed/34795995 http://dx.doi.org/10.17691/stm2020.12.4.09 |